Drug class
Kinase Inhibitor
Mechanism of action
Bcr-Abl Tyrosine Kinase Inhibitors
General use cases
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Hypereosinophilic Syndrome
- Dermatofibrosarcoma
- Mastocytosis, Systemic
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
